Hundreds of new counterparties are now in scope of the margin rules for uncleared derivatives in a milestone that was supposed to happen a year ago but got put back due to Covid.
As we warned in our Olympic regulatory round up piece a month ago, plenty were not fully ready with signed IM documents and custodial arrangements in place. There was just too much legal and operational work with other priorities weighing on people’s time.
However, there is some respite in the short term in the form of ‘Threshold Monitoring‘. As long as you don’t exceed €/$50m in calculated initial margin at group level, then the IM obligations do not kick in. Counterparties, either as a result of running out of time, or as a deliberate strategy as they don’t think they will get near the threshold, have put in place monitoring.
Of course, this could be a risky strategy as market conditions might rapidly change leaving counterparties unable to trade bilateral swaps and in regulatory non-compliance.
First of course is to finish Phase 5 – work continues between legal and collateral operations teams to tidy-up remaining relationships that need to be documented. But with that done the fun is not over, as focus will rapidly shift to Phase 6 – FCs (Financial counterparties) and NFC+s (Non-financial counterparties that exceed one of the clearing thresholds) with AANA (Aggregate Average Notional Amount) in uncleared derivatives above €8bn (down from the Phase 5 level of €50bn). Phase 6 deadline is a year from now, 1 September 2022.
And what have we learnt?
Just to reflect on a few themes that emerged during Phase 5, and no doubt will continue to manifest as we move into Phase 6:
Custodians: there are long lead times for setting-up new custodian arrangements that as much as anything dictate the eventual timelines for completion. And extra time is needed for Know Your Customer/onboarding if new custodians are involved.
Scope: working-out who is in scope of the new rules is not trivial, especially given thresholds are applied at consolidated group level potentially across multiple operating entities; confusing factors like FX deliverables contributing to AANA but not being IM products adds to the complexity.
Standardisation: there is a lack of industry standards, e.g. for threshold monitoring...at what levels, how documented? Also standardised SWIFT messages from custodians for settlement. There is likely scope to streamline the whole documentation and operational process to improve end-to-end timelines.
SIMM v Grid: the methodology for calculating expected collateral levels...generally SIMM was used in the past, but increasingly with directional portfolios, or as a result of operational constraints for some products/counterparties, Grid being used now as well (see ISDA’s paper for more on this).
Cross jurisdictional: entities outside uncleared margin rules drawn into scope by facing entities subject to the rules, but are more reluctant to engage; also the possible divergence in rules e.g. between EU and UK post-Brexit may present challenges in the future.
All in all, it has been a bit of a scramble to the 1 September 2021 finish line, and quite a few will limp across the line after the race is over, but broadly due to Threshold Monitoring we are unlikely to see substantial disruption to trading activity in the near term.
Time will tell whether all can keep within their agreed limits, and how things will start to play out as the industry gears up for Phase 6.
FCs - Financial counterparties
FC+s - Non-financial counterparties (that exceed one of the clearing thresholds)
SIMM - Standard Initial Margin Model
Grid - Schedule provided by the respective regulator
This article has been prepared for information purposes only, does not constitute an analysis of all potentially material issues and is subject to change at any time without prior notice. NatWest Markets does not undertake to update you of such changes. It is indicative only and is not binding. Other than as indicated, this article has been prepared on the basis of publicly available information believed to be reliable but no representation, warranty, undertaking or assurance of any kind, express or implied, is made as to the adequacy, accuracy, completeness or reasonableness of the information contained in this article, nor does NatWest Markets accept any obligation to any recipient to update or correct any information contained herein. Views expressed herein are not intended to be and should not be viewed as advice or as a personal recommendation. The views expressed herein may not be objective or independent of the interests of the authors or other NatWest Markets trading desks, who may be active participants in the markets, investments or strategies referred to in this article. NatWest Markets will not act and has not acted as your legal, tax, regulatory, accounting or investment adviser; nor does NatWest Markets owe any fiduciary duties to you in connection with this, and/or any related transaction and no reliance may be placed on NatWest Markets for investment advice or recommendations of any sort. You should make your own independent evaluation of the relevance and adequacy of the information contained in this article and any issues that are of concern to you.
This article does not constitute an offer to buy or sell, or a solicitation of an offer to buy or sell any investment, nor does it constitute an offer to provide any products or services that are capable of acceptance to form a contract. NatWest Markets and each of its respective affiliates accepts no liability whatsoever for any direct, indirect or consequential losses (in contract, tort or otherwise) arising from the use of this material or reliance on the information contained herein. However this shall not restrict, exclude or limit any duty or liability to any person under any applicable laws or regulations of any jurisdiction which may not be lawfully disclaimed.
NatWest Markets Plc. Incorporated and registered in Scotland No. 90312 with limited liability. Registered Office: 36 St Andrew Square, Edinburgh EH2 2YB. Authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and Prudential Regulation Authority. NatWest Markets N.V. is incorporated with limited liability in the Netherlands, authorised and regulated by De Nederlandsche Bank and the Autoriteit Financiële Markten. It has its seat at Amsterdam, the Netherlands, and is registered in the Commercial Register under number 33002587. Registered Office: Claude Debussylaan 94, Amsterdam, the Netherlands. Branch Reg No. in England BR001029. NatWest Markets Plc is, in certain jurisdictions, an authorised agent of NatWest Markets N.V. and NatWest Markets N.V. is, in certain jurisdictions, an authorised agent of NatWest Markets Plc. NatWest Markets Securities Japan Limited [Kanto Financial Bureau (Kin-sho) No. 202] is authorised and regulated by the Japan Financial Services Agency. Securities business in the United States is conducted through NatWest Markets Securities Inc., a FINRA registered broker-dealer (http://www.finra.org), a SIPC member (www.sipc.org) and a wholly owned indirect subsidiary of NatWest Markets Plc.